SCHEMBL20522011

SCHEMBL20522011

O=C(O)NC(c1ccc(Cl)cc1)S(=O)(=O)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.48
ALDH1A1 P00352 2/20 0.46
CNR2 P34972 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
EGFR P00533 1/20 0.42
ERBB2 P04626 1/20 0.42
HSD11B1 P28845 2/20 0.42
FLT1 P17948 1/20 0.42
FLT4 P35916 1/20 0.42
KDR P35968 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ATM Q13315 1/20 0.42
LMNA P02545 1/20 0.41
MAPT P10636 2/20 0.40
HTT P42858 1/20 0.40
ENPP3 O14638 1/20 0.40
ENPP1 P22413 1/20 0.40
KDM4E B2RXH2 2/20 0.39
GAA P10253 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10668539 0.94 CNR1 (0.43) CNR1ALDH1A1MEN1KMT2AFLT1
SCHEMBL15912974 0.84 CNR1 (0.48) CNR1ALDH1A1CNR2MEN1KMT2A
SCHEMBL23205656 0.81 S1PR3 (0.45) CNR1ALDH1A1ATMMAPT
SCHEMBL15913194 0.81 EEF2K (0.46) L3MBTL1MAPTKDM4EGAA
SCHEMBL4256511 0.79 LMNA (0.48) ALDH1A1LMNAGAATP53
SCHEMBL3446823 0.78 ATM (0.42) ALDH1A1EGFRATMLMNAKDM4E
SCHEMBL17291348 0.78 LMNA (0.50) ALDH1A1CNR2MEN1KMT2AEGFR
SCHEMBL3446516 0.75 MEN1 (0.42) MEN1KMT2AATMLMNAMAPT
SCHEMBL2367712 0.75 NAMPT (0.53) ALDH1A1MAPTGAA
SCHEMBL8560061 0.74 ALDH1A1 (0.54) ALDH1A1MEN1KMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230278989-A1 ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION AND PROCESS FOR MAKING THEM ASTEX THERAPEUTICS LIMITED (GB) 2023-09-07 US disclosed
US-11603367-B2 Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them ASTEX THERAPEUTICS LIMITED (GB) 2023-03-14 US disclosed
US-20210101887-A1 ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION AND PROCESS FOR MAKING THEM ASTEX THERAPEUTICS LIMITED (GB) 2021-04-08 US disclosed
EP-3601272-A1 ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION AND PROCESS FOR MAKING THEM Astex Therapeutics Limited (GB) 2020-02-05 EP disclosed
WO-2018178691-A1 ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION AND PROCESS FOR MAKING THEM ASTEX THERAPEUTICS LIMITED (GB) 2018-10-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11603367-B2 Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them MDM2, TP53, TP53BP1 CNR1 4582/4885ALDH1A1 192/4885CNR2 4755/4885
US-20230278989-A1 ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION AND PROCESS FOR MAKING THEM MDM2, TP53, TP53BP1 CNR1 4582/4885ALDH1A1 192/4885CNR2 4755/4885
US-20210101887-A1 ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION AND PROCESS FOR MAKING THEM MDM2, TP53, TP53BP1 CNR1 4582/4885ALDH1A1 192/4885CNR2 4755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.